SMARCA4 and pancreatic intraductal papillary-mucinous neoplasm: Mechanistically, loss of Smarca4 promoted dedifferentiation of pancreatic ductal cells expressing oncogenic KrasG12D and led to development of IPMN lesions in vivo.